首页> 外文期刊>The American Journal of Clinical Nutrition: Official Journal of the American Society for Clinical Nutrition >Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract.
【24h】

Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract.

机译:人乳寡糖对上消化道中的酶水解具有抗性。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Human milk oligosaccharides (HMOs) show a complexity and variety not found in milk of any other species. Although progress has been made in the past 3 decades with regard to identification and structural characterization of HMOs, not much is known about the physiologic functions of HMOs. OBJECTIVE: As a prerequisite for biological activity in infant metabolism, HMOs have to resist enzymatic hydrolysis in the gastrointestinal tract. To assess the extent to which selected HMOs are hydrolyzed, we carried out in vitro digestion studies using enzyme preparations of human and porcine pancreas and intestinal brush border membranes (BBMs). DESIGN: Fractions of HMOs, including structurally defined isolated oligosaccharides, were digested for up to 20 h with human pancreatic juice and BBMs prepared from human or porcine intestinal tissue samples. HMOs were incubated by using a porcine pancreatic homogenate and BBMs as enzyme sources. HMOs and digestion products were identified by mass spectrometry and anion-exchange chromatography. Additionally, free D-glucose, L-fucose, and N-acetylneuraminic acid were determined enzymatically. RESULTS: Whereas maltodextrin (control) was rapidly and completely hydrolyzed, neutral and acidic HMOs showed a profound resistance against pancreatic juice and BBM hydrolases. However, cleavage of most of the HMOs was achieved by using a pancreatic homogenate containing intracellular, including lysosomal, enzymes in addition to secreted enzymes. CONCLUSIONS: The results of this study strongly suggest that HMOs are not hydrolyzed by enzymes in the upper small intestine. Although intact HMOs may be absorbed, we postulate that a majority of HMOs reach the large intestine, where they serve as substrates for bacterial metabolism. Therefore, HMOs might be considered the soluble fiber fraction of human milk.
机译:背景:人乳低聚糖(HMO)显示出其他任何种类的乳中都没有的复杂性和多样性。尽管在过去的30年中在HMO的鉴定和结构表征方面取得了进展,但对HMO的生理功能了解不多。目的:作为婴儿代谢中生物学活性的先决条件,HMO必须抵抗胃肠道中的酶水解。为了评估所选HMO的水解程度,我们使用人和猪胰腺的酶制剂以及肠刷缘膜(BBM)进行了体外消化研究。设计:用人类胰液和从人或猪肠组织样品中制备的BBM将HMO的馏分(包括结构明确的分离的寡糖)消化长达20小时。通过使用猪胰匀浆和BBM作为酶源温育HMO。通过质谱和阴离子交换色谱法鉴定HMO和消化产物。另外,通过酶法测定游离的D-葡萄糖,L-岩藻糖和N-乙酰神经氨酸。结果:麦芽糖糊精(对照物)被迅速完全水解,而中性和酸性的HMOs对胰液和BBM水解酶具有很强的抵抗力。但是,大多数HMO的裂解是通过使用胰匀浆来实现的,匀浆除了分泌的酶外,还含有胞内酶,包括溶酶体酶。结论:这项研究的结果强烈表明,HMOs不会被小肠上部的酶水解。尽管完整的HMO可能会被吸收,但我们假设大多数HMO到达大肠,在大肠中它们充当细菌代谢的底物。因此,HMO可能被认为是人乳中的可溶性纤维部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号